PC4 AnnualReport 19/20 - Page 3



3
JON EMERY
We have continued to ride a wave of
success since our 10th anniversary last
year. 2019/20 was a record-breaking
year, with over $10 million in funding
awarded. I want to congratulate our
members on their hard work. This
funding will see more than 15 new
cancer in primary care studies begin,
despite the impact of COVID-19 on
research activity.
“2019/20 HAS BEEN A
RECORD-BREAKING YEAR,
WITH OVER $10 MILLION
IN FUNDING AWARDED.
THIS FUNDING WILL SEE
MORE THAN 15 NEW
CANCER IN PRIMARY CARE
STUDIES BEGIN”
Our focus on communication and
design support has helped us move into
a new phase with a range of resources
and support available for our members.
We’ve paid attention to producing
quality trial recruitment materials
as well as external facing content to
disseminate and share the impact of
our research.
I would like to highlight the continued
importance of embedding consumers
in all aspects of PC4’s research
development and conduct.
Lastly, our new Consumer Engagement
model has been designed to help
us connect with more consumers. It
ensures that consumer investigators
are part of all funding applications
and pushes the consumer voice to the
forefront during trial development.
Jon Emery,
Director PC4





Powered by


Full screen Click to read
Paperturn flipbook system
Search
Overview
Download as PDF
Print
Shopping cart
Full screen
Exit full screen